![]() |
|
|
Vol. 27, Issue 7, 848-854, July 1999
Research Triangle Institute (L.A.B., D.P.C., J.P.B., B.F.T.,
A.R.J.); and National Institute for Environmental Health Sciences
(L.T.B.), Research Triangle Park, North Carolina
Isoprene, a major commodity chemical used in production of
polyisoprene elastomers, has been shown to be carcinogenic in
rodents. Similar to findings for the structurally related
compound butadiene, mice are more susceptible than rats to
isoprene-induced toxicity and carcinogenicity. Although differences in
uptake, and disposition of isoprene in rats and mice have been
described, its in vivo biotransformation products have not been
characterized in either species. The purpose of these studies was to
identify the urinary metabolites of isoprene in Fischer 344 rats and
compare these metabolites with those formed in male B6C3F1
mice. After i.p. administration of 64 mg [14C]isoprene/kg
to rats and mice, isoprene was excreted unchanged in breath (~50%)
or as urinary metabolites (~32%). In rats isoprene was primarily
excreted in urine as 2-hydroxy-2-methyl-3-butenoic acid (53%),
2-methyl-3-buten-1,2-diol (23%), and the C-1 glucuronide conjugate of
2-methyl-3-buten-1,2-diol (13%). These metabolites are consistent with
preferential oxidation of isoprene's methyl-substituted vinyl group.
No oxidation of the unsubstituted vinyl group was observed. In addition
to the isoprene metabolites found in rat urine, mouse urine contained
numerous other isoprene metabolites with a larger percentage (25%) of
total urinary radioactivity associated with an unidentified, polar
fraction than in the rat (7%). Unlike butadiene, there was no evidence
that glutathione conjugation played a significant role in the
metabolism of isoprene in rats. Because of the unidentified metabolites
in mouse urine, involvement of glutathione in the metabolism of
isoprene in mice cannot be delineated.